<DOC>
	<DOCNO>NCT02382588</DOCNO>
	<brief_summary>The purpose study evaluate efficiency topical gancyclovir 0.15 % treatment herpes zoster keratitis . Half patient receive study drug half patient receive placebo</brief_summary>
	<brief_title>Comparison Topical 0.15 % Gancyclovir Gel Versus 0.3 % Hypromellose Gel Treatment Herpes Zoster Keratitis</brief_title>
	<detailed_description>Patients herpes zoster keratitis enrol study . All patient receive oral anti-viral medication standard-of-care therapy . The patient randomize two group give either study drug placebo time enrollment . The patient come weekly visit slit lamp photograph dendrite take . At week 2 , dendrite heal drug unmasked rescue therapy give . patient examine week 1 , 2 , 3 resolution occurs .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Keratitis</mesh_term>
	<mesh_term>Herpes Zoster Ophthalmicus</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>age 18 gancyclovir gel form topical antiviral therapy past month able willing attend subsequent followup visit Associated retinitis patient allergic gancyclovir patient require systemic intravitreal gancyclovir therapy patient pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>